NCT04028258

Brief Summary

Once the patients who are candidates to enter the study are identified, the patients will be randomly be assigned to two groups, according to the sequence:

  • Group A: study product+wash out+control product
  • Group B: control product+wash out+study product

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 13, 2018

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

July 15, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 22, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

March 9, 2020

Status Verified

March 1, 2020

Enrollment Period

2.8 years

First QC Date

July 15, 2019

Last Update Submit

March 6, 2020

Conditions

Keywords

ConstipationFiber

Outcome Measures

Primary Outcomes (1)

  • Percentage of clinical change obtained from the difference between the initial value and the final value for a combined score of the frequency of passage of faeces, pain to defecation, consistency of stool.

    Combined score between this parameters

    From baseline to 8 weeks

Secondary Outcomes (8)

  • Consistency of stool according to Bristol Stool Form Scale

    From baseline to 8 weeks

  • Frequency of stool

    From baseline to 8 weeks

  • Change in stool weight

    From baseline to 8 weeks

  • Gastrointestinal symptoms related to the constipation

    From baseline to 8 weeks

  • Adherence record to the complement intake (Moriski Green test)

    At 8 weeks

  • +3 more secondary outcomes

Study Arms (2)

Group A: study+wash out+control

OTHER

Study product (3 weeks) + wash out (2 weeks) + control product (3 weeks)

Dietary Supplement: Mixture of fibers + Placebo

Group B: control+wash out+study

OTHER

Control product (3 weeks) + wash out (2 weeks) + study product (3 weeks)

Dietary Supplement: Placebo + Mixture of fibers

Interventions

Mixture of fibers + PlaceboDIETARY_SUPPLEMENT

Study product: mixture of plant-based food fibers (3 weeks) + wash out (2 weeks) + placebo control : plum flakes + maltodextrin (3 weeks)

Group A: study+wash out+control
Placebo + Mixture of fibersDIETARY_SUPPLEMENT

Placebo control: plum flakes + maltodextrin (3 weeks) + wash out (2 weeks) + study product: mixture of plant-based food fibers (3 weeks)

Group B: control+wash out+study

Eligibility Criteria

Age3 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Boys and girls aged 3 to 12
  • Diagnosis of functional constipation according to Rome IV criteria

You may not qualify if:

  • Regular use of a dietary fiber supplement, prebiotics or probiotics in the previous 30 days, or who would have been taking bulk-forming agents or laxatives in the 2 weeks prior to the study
  • Use of medications that cause constipation
  • Children with organic constipation such as Hirschsprung's disease, cerebral paralysis, anorectal and spinal cord abnormalities and metabolic diseases.
  • Patients who are not likely to complete follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Centro de Salud Perpetuo Socorro

Huesca, Aragon, 22006, Spain

RECRUITING

Centro de Salud Amparo Poch

Zaragoza, Aragon, 50018, Spain

RECRUITING

Centro de Salud Isabel II

Santander, Cantabria, 39002, Spain

RECRUITING

MeSH Terms

Conditions

Constipation

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Gerardo Rodríguez, MD

    Instituto de Investigación Sanitaria Aragón

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Roser De Castellar, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2019

First Posted

July 22, 2019

Study Start

February 13, 2018

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

March 9, 2020

Record last verified: 2020-03

Locations